Mandate

Vinge advises Industrifonden in connection with investment in Footway

January 26, 2012

Vinge has advised Industrifonden in connection with its investment in Footway, an e-trading company which sells shoes online. The investment was part of a new issue of shares under which Footway raised SEK 28 million from Industrifonden, eEquity and the company’s founders.  One of the key figures in Footway is Daniel Mühlbach, who played a prominent role in the success of Lensway. The money will be used for Footway’s expansion in the Nordic region.

Industrifonden invests in small and medium sized companies which exhibit the potential for international growth. The fund has assets of SEK 3.8 billion and investments in 89 companies within the technology, cleantech, life science and industrial sectors. 

Vinge’s team consisted of partner Johan Larsson and associate Martin Hall.

Related

Vinge has advised Hansa Biopharma in connection with entering into a financing agreement

Vinge has advised Hansa Biopharma AB (publ), a commercial-stage biopharmaceutical company on a mission to develop and commercialize innovative, lifesaving and life-altering treatments for patients with rare immunological conditions, listed on Nasdaq Stockholm, in connection with a U.S. convertible note purchase agreement comprising USD 30 million aggregate principal amount of unsecured convertible senior notes.
March 23, 2026

Vinge advises in connection with data center provider EcoDataCenter’s tap issue of SEK 500 million bonds

Vinge has advised in connection with EcoDC Holding AB (publ)'s tap issue of SEK 500 million senior unsecured bonds under the existing framework of up to SEK 2 billion.
March 19, 2026

Vinge has advised Cinclus Pharma in connection with entering into financing agreement

Vinge has advised Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases listed on Nasdaq Stockholm, in connection with a long-term structured credit agreement for a total of up to EUR 28 million divided into four tranches, of which two are convertibles.
March 16, 2026